Useful Resources

ATMPs and their groundbreaking potential – a holistic overview

Advanced Therapy Medicinal Products (ATMPs) and their groundbreaking potentialDownload

Preparing European health systems for ATMPs

Preparing European health systems for Advanced Therapy Medicinal Products (ATMPs)Download

What are Advanced Therapies Medicinal Products (ATMPs)?

  • Advanced Therapy Medicinal Products: Overview

    View
  • Briefing Session

    Gene Therapies: Transforming the lives of patients today – Bakhuti Shengelia (Novartis)

    Watch
  • Briefing Session

    The value of cell and gene therapies for patients and healthcare systems – Avril Daly (Retina International)

    Watch
  • Briefing Session

    Understanding the promise of cell and gene therapies – Prof. Francesco Muntoni (UCL)

    Watch

The Lifecycle of ATMPs: from Early Diagnosis to Access to Patients

  • How can we maximise the value of cell and gene therapies through early detection?
  • Briefing Session

    Introductions by MEP Pietikäinen & MEP Kympouropoulos

    Speakers:

    MEP Sirpa Pietikainen (EPP, FI)

    MEP Stelios Kympouropoulos (EPP, GR)

    Victor Maertens, Government Affairs Manager, EUCOPE

    Read more ↓
    Watch
  • Briefing Session

    Martine Pergent (IPOPI)

    Watch
  • Briefing Session

    Tim Wilsdon (CRA)

    Watch
  • How to make Europe more attractive for cell and gene therapy development?
  • Briefing Session

    Introductions by MEP Pernille Weiss (EPP, DK), MEP Radka Maxova (S&D, CZ) and Victor Maertens (EUCOPE)

    Module 6: How to make Europe more attractive for gene and cell therapy development?

    • MEP Pernille Weiss (EPP, DK)
    • MEP Radka Maxova (S&D, CZ)
    • Victor Maertens (Government Affairs Manager, EUCOPE)
    Read more ↓
    Watch
  • Briefing Session

    Christina Kyriakopoulou (DG RTD)

    Watch
  • Briefing Session

    Adam Hutchings (Dolon)

    Watch
  • Briefing Session

    Frédéric Druck (essencia/bio.be)

    Watch
  • How are cell and gene therapies manufactured?
  • Briefing Session

    Brid Carberry (Novartis)

    Watch

  • Gene Therapy Manufacturing – PTC Centre of Excellence

    View
  • Gene & cell therapy regulation and what it means for the revision of the pharmaceutical legislation?
  • Briefing Session

    Introduction by Alexander Natz (EUCOPE)

    Watch
  • Briefing Session

    Martina Schussler-Lenz (EMA Committee for Advanced Therapies, Paul-Ehrlich Institute)

    Watch
  • Briefing Session

    Simone Boselli (EURORDIS)

    Watch
  • Towards better use and exchange of Real-World Evidence for cell and gene therapies
  • Briefing Session

    Introduction by MEP Susana Solis, MEP Manuel Pizarro & Victor Maertens (EUCOPE)

    Watch
  • Briefing Session

    Elke Grooten (Novartis)

    Watch
  • Briefing Session

    Guillaume Byk (DG SANTE)

    Watch
  • Briefing Session

    Jo De Cock (INAMI-RIZIV)

    Watch
  • Briefing Session

    Alessandra Ferlini (Medical Geneticist & Neurologist, ERN representative)

    Watch

Literature

  • Event Report

    INAMI (2019), Innovative funding solutions for paradigm changing advanced therapy medicinal products (ATMP) in Belgium

    View
  • Academic Article

    van Overbeeke et al (2020), Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions

    View
  • Academic Article

    Reineke et al (2022), Market access to new anticancer medicines for children and adolescents with cancer in Europe

    View
  • Academic Article

    Gene therapy in the putamen for curing AADC deficiency and Parkinson’s disease

    View

European Gene and Cell Therapy Database

  • European Gene and Cell Therapy Database

    View